AXSOME THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
AXSOME THERAPEUTICS, INC. (AXSM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 3.13 thousand shares for the 3-month period ending 2019-03-31, per its 10-Q filed 2019-05-09.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2019-05-09
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-03-31 was 3.13K shares, a 311.84% increase year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2018-12-31 was 210.66K shares, a 116.21% increase year-over-year.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2018-09-30 was 25.01K shares.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2018-06-30 was 0.00 shares.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2018 was 236.44K shares, a 108.31% increase from fiscal 2017.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2017 was 113.50K shares, a 12681.87% increase from fiscal 2016.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2016 was 888.00 shares, a 84.89% decline from fiscal 2015.
- AXSOME THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2015 was 5.88K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|
| 2019-03-31 | 3.13K shares 10-Q · filed 2019-05-09 | 213.79K shares derived: sum of 2 quarters · filed 2019-05-09 | 238.81K shares derived: sum of 3 quarters · filed 2019-05-09 | 238.81K shares derived: sum of 4 quarters · filed 2019-05-09 |
| 2018-12-31 | 210.66K shares derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-15 | 235.68K shares derived: sum of 2 quarters · filed 2019-03-15 | 235.68K shares derived: sum of 3 quarters · filed 2019-03-15 | 236.44K shares 10-K · filed 2019-03-15 |
| 2018-09-30 | 25.01K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-09 | 25.01K shares derived: sum of 2 quarters · filed 2018-11-09 | 25.77K shares 10-Q · filed 2018-11-09 | 123.21K shares derived: sum of 4 quarters · filed 2018-11-09 |
| 2018-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 760.00 shares 10-Q · filed 2018-08-08 | 98.19K shares derived: sum of 3 quarters · filed 2018-08-08 | 98.19K shares derived: sum of 4 quarters · filed 2018-08-08 |
| 2018-03-31 | 760.00 shares 10-Q · filed 2018-05-08 | 98.19K shares derived: sum of 2 quarters · filed 2018-05-08 | 98.19K shares derived: sum of 3 quarters · filed 2018-05-08 | |
| 2017-12-31 | 97.44K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 97.44K shares derived: sum of 2 quarters · filed 2018-03-07 | 113.50K shares 10-K · filed 2018-03-07 | |
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | 16.07K shares 10-Q · filed 2017-11-08 | ||
| 2017-06-30 | 16.07K shares 10-Q · filed 2017-08-09 | |||
| 2016-12-31 | 888.00 shares 10-K · filed 2017-03-07 | |||
| 2016-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2016-08-09 | 0.00 shares 10-Q · filed 2016-08-09 | ||
| 2016-03-31 | 0.00 shares 10-Q/A · filed 2016-08-09 | |||
| 2015-12-31 | 5.88K shares 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |